Literature DB >> 30550809

The Asthma Controller Step-down Yardstick.

Bradley E Chipps1, Leonard B Bacharier2, Kevin R Murphy3, David Lang4, Judith R Farrar5, Matthew Rank6, John Oppenheimer7, Robert S Zeiger8.   

Abstract

Asthma guidelines recommend a control-based approach to disease management in which the assessment of impairment and risk is linked to step-based therapy. Using this model, controller treatment is adjusted-upward or downward-according to a patient's level of asthma control over time. Strategies for stepping up controller therapy are well described, and the adult and pediatric Asthma Yardsticks provide operational recommendations based on patient profiles. Strategies for stepping down controller treatment are less clear, although stepping down to the minimum effective therapy is important and should be considered when a patient's asthma has been well controlled for an adequate period as defined by risk and impairment. This Yardstick presents recommendations for when and how to step down asthma controller therapy according to guideline-defined control levels. The objective is to provide clinicians who treat patients with asthma with a practical and clinically relevant framework for implementing a step-down in controller therapy.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30550809     DOI: 10.1016/j.anai.2018.12.004

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  2 in total

1.  Qualitative Study of Practices and Challenges of Stepping Down Asthma Medication in Primary Care Across the UK.

Authors:  Azeem Majeed; Austen El-Osta; Chloe I Bloom; Helen Ramsey; Marsha Alter; Shivali Lakhani; Ernie Wong; Katharine Hickman; Sarah L Elkin
Journal:  J Asthma Allergy       Date:  2020-10-06

2.  Stepping down therapy for well-controlled mild asthma: an experience from University Medical Center at Ho Chi Minh City.

Authors:  Nguyen-Ho Lam; Nguyen-Thanh Nam; Le-Thuong Vu; Nguyen-Nhu Vinh; Le-Thi Tuyet-Lan
Journal:  Asia Pac Allergy       Date:  2021-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.